Report cover image

Non-steroidal Anti-inflammatory Drugs Market Growth, Size, Trends Analysis - By Disease Indication, By Route of Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Feb 11, 2025
Length 257 Pages
SKU # SPER19805271

Description

Non-steroidal Anti-inflammatory Drugs Market Introduction and Overview

According to SPER market research, ‘Global Non-steroidal Anti-inflammatory Drugs Market Size- By Disease Indication, By Route of Administration, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Non-steroidal Anti-inflammatory Drugs Market is predicted to reach 40.44 billion by 2034 with a CAGR of 5.92%.

Nonsteroidal anti-inflammatory medications are often used to treat pain, inflammation, and fever. They are commonly used to relieve arthritis, muscle aches, headaches, menstrual cramps, and minor injuries such as sprains and strains. NSAIDs inhibit the formation of substances called prostaglandins in the body, which are responsible for pain and inflammation. These drugs, such as ibuprofen (Advil, Motrin) and naproxen (Aleve), are frequently available in over-the-counter and prescription strength formulations.

Restraints: The broad use of NSAIDs is limited by the possibility of major side effects such as cardiovascular events, gastrointestinal issues, renal failure, and hypersensitivity responses. Despite the relatively low individual risk for each patient, the cumulative usage of NSAIDs throughout populations increases the overall risk of adverse effects. This needs a rigorous review of individual patient risk factors before to prescribing NSAIDs, limiting the growth of the anti-inflammatory medications industry.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Disease Indication, By Route of Administration, By Distribution Channel.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Pfizer Inc, Bayer AG, GSK plc, Dr. Reddys Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd, Johnson and Johnson Services, Merck & Co, Inc. and others.

Non-steroidal Anti-inflammatory Drugs Market Segmentation:

By Disease Indication: Based on the Disease Indication, Global Non-steroidal Anti-inflammatory Drugs Market is segmented as; Arthritis, Migraine, Ophthalmic Diseases, Others.

By Route of Administration: Based on the Route of Administration, Global Non-steroidal Anti-inflammatory Drugs Market is segmented as; Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

257 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Non-steroidal Anti-inflammatory Drugs Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Non-steroidal Anti-inflammatory Drugs Market
7. Global Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication (USD Million) 2021-2034
7.1. Arthritis
7.2. Migraine
7.3. Ophthalmic Diseases
7.4. Others
8. Global Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration (USD Million) 2021-2034
8.1. Oral
8.2. Topical
8.3. Others
9. Global Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel (USD Million) 2021-2034
9.1. Hospital Pharmacy
9.2. Retail Pharmacy
9.3. Online Pharmacy
10. Global Non-steroidal Anti-inflammatory Drugs Market, (USD Million) 2021-2034
10.1. Global Hospital Pharmacy
10.2. Retail Pharmacy
10.3. Online Pharmacy Market Size and Market Share
11. Global Non-steroidal Anti-inflammatory Drugs Market, By Region, (USD Million) 2021-2034
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Pfizer Inc
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Bayer AG
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. GSK plc
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Dr. Reddys Laboratories Ltd
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Viatris Inc
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Teva Pharmaceutical Industries Ltd
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Johnson and Johnson Services, Inc
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Merck & Co., Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us